JPJacob Pitaro

Jacob Pitaro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacob Pitaro has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Haim Gavriel

    Department of Otolaryngology-Head and Neck Surgery, Shamir Medical Center, Zerifin, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel

    3 shared publications
  • Limor Muallem-Kalmovich

    Department of Otolaryngology-Head and Neck Surgery, Shamir Medical Center, Zerifin, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel

    3 shared publications
  • Tal Marom

    Department of Otolaryngology-Head and Neck Surgery, Samson Assuta Ashdod University Hospital, Ashdod, Israel

    3 shared publications
  • Avital Fellner

    Department of Otolaryngology-Head and Neck Surgery, Shamir (Assaf Harofeh) Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel

    2 shared publications
  • Ephraim Eviatar

    Department of Otolaryngology-Head and Neck Surgery, Assaf Harofeh Medical Center, Tel Aviv University, Sackler School of Medicine, 70300, Zerifin, Israel

    2 shared publications
  • Limor Muallem Kalmovich

    Department of Otolaryngology‐Head and Neck Surgery Shamir Medical Centre Be'er Ya'akov Israel

    2 shared publications

Latest Publications

  • Open Access

    The efficacy of oral montelukast versus intranasal fluticasone furoate in reducing the severity of pediatric sleep-disordered breathing: A randomized clinical trial

    by Sarah Rothman, Ronly Har-Even, Ofer Israel, Arnon Elizur, Limor Muallem-Kalmovich, Haim Gavriel, Claudio Vicini, Jacob Pitaro

  • Open Access

    Identifying Failure Predictors in Thyroid Nodule Radiofrequency Ablation Using Multivariate Analysis: A Single‐Centre Experience

    by Shmuel Wechsler, Tanya Shcherbaeva, Jacob Pitaro, Limor Muallem Kalmovich

    Background: Radiofrequency ablation (RFA) has become an established minimally invasive treatment for benign thyroid nodules (BTN), offering excellent safety and efficacy. However, factors predicting treatment success and post‐procedural thyroid dysfunction remain incompletely understood. This study aimed to perform a preliminary evaluation of clinical, procedural, and biochemical predictors of RFA outcomes in a real‐world consecutive patient cohort. Study Design and Methods: A retrospective analysis was conducted on consecutive patients who underwent ultrasound‐guided RFA for cytologically benign thyroid nodules between January 2018 and March 2024 at a single tertiary medical centre. Demographic, sonographic, procedural, and biochemical variables, including thyroid‐stimulating hormone (TSH), thyroglobulin (Tg), and anti‐Tg antibodies, were analysed. The primary endpoint was the Volume Reduction Ratio (VRR), with ≥ 50% defined as procedural success. Results: Sixty‐two patients (mean age 52.6 years; 85.5% female) were included. The median best VRR achieved was 61.9% (IQR 46.6–74.5), with 71% of patients attaining ≥ 50% reduction. Higher pre‐treatment Tg levels were significantly associated with reduced VRR ( p < 0.001) and remained independently associated with procedural failure in an exploratory multivariable model (OR 0.87 per 10 ng/mL increase, p = 0.011). Pretreatment TSH levels showed a univariate positive trend but did not reach statistical significance on multivariate analysis. Two patients (3.2%) developed hypothyroidism post‐RFA, both with positive anti‐Tg antibodies (total 13 patients had positive anti Tg Ab). The overall complication rate was 6.5%, with no major adverse events. Conclusions: Our results suggest that pre‐treatment thyroglobulin levels may serve as a potential biochemical predictor of RFA success in benign thyroid nodules, while antibody positivity may suggest susceptibility to post‐ablation hypothyroidism. While most existing literature focuses on imaging features (e.g., sonographic features) or surgeon technique, our findings highlight the unique importance of biochemical characteristics. Incorporating biochemical profiling into pre‐procedural assessment could refine patient selection and enhance individualised treatment planning. Future prospective studies are warranted to validate Tg as a biomarker of RFA response.

  • Has COVID-19 Changed Pediatric Acute Rhinosinusitis Epidemiology During the First 2 Pandemic Years?

    by Itai BMedSc Hazan, Oren Ziv, Tal Marom, Elchanan Md Zloczower, Jacob Md Pitaro, Meir Warman

    Objective: To study national pediatric acute rhinosinusitis (ARS) burden fluctuations before and during the first 2 coronavirus-19 (COVID) years, characterized by alternating lockdown and relaxation periods, the introduction of COVID vaccines, and the emergence of nonalpha COVID variants. Methods: This was a cross-sectional, population-based study covering the 3 pre-COVID years and the first 2 COVID years from a big database of the largest Israeli Health Maintenance Organization. For comparison purposes, we explored ARS burden trends with those of urinary tract infection (UTI), which is unrelated to viral diseases. We identified children P < 0.001). Although UTI episode rates also decreased during COVID (IRR 0.79, 95% CI: 0.72–0.86, P < 0.001), the reduction in ARS burden was 3-fold higher. The dominant pediatric ARS age group was between 5 and 15 years. The largest decrease in ARS burden was during the first COVID year. ARS episode distribution showed a seasonal fluctuation, with a peak during the summer months during the COVID years. Conclusions: Pediatric ARS burden decreased during the first 2 COVID years. Episode distribution was noted to be year-round.


  • Caustic Ingestion in Children

    by Tanya Shcherbaeva, Limor Muallem Kalmovich, Tzippora Shalem, Efrat Broide, Haim Gavriel, Jacob Md Pitaro

    Objectives: Caustic ingestion in children is a significant cause of morbidity despite preventive measures. Upon arrival to the emergency department, these children are often initially seen by the otolaryngologist and later on by the gastroenterologist. This study aimed to determine which otolaryngological and gastrointestinal signs and symptoms can better predict abnormal findings on imaging, esophagogastroduodenoscopy (EGD), and complications development. Methods: We performed a retrospective chart review of children 18 years or younger admitted because of caustic ingestion between January 2007 and November 2019. Results: Forty-one children with a median age of 4.2 years (interquartile range, 1.7–16.7 years) were included; of them, 22 (53.6%) were males. Nineteen children (46.3%) underwent EGD, which revealed no pathology in 13 cases (68.4%). Most ingested substances were in the form of liquid (82.9%), accidentally ingested (82.9%), and with an alkaline pH (57.5%). Stridor, dyspnea, drooling, abnormal oral cavity findings, dysphagia, and vomiting were significantly associated with pathological findings on imaging and/or EGD and/or complications development (P = 0.028, P = 0.028, P = 0.022, P = 0.02, P < 0.001, and P = 0.01 respectively). Laryngopharyngeal group of findings (dyspnea, stridor, hoarseness, sore throat, and/or drooling) predicted a higher risk for complications development than the gastrointestinal group (dysphagia, abdominal pain, vomiting, or abdominal swelling and/or tenderness) (P = 0.011, P = 0.31 respectively). Conclusions: In children, after caustics ingestion, laryngopharyngeal signs and symptoms may predict a higher risk for complications development in comparison with gastrointestinal signs and symptoms. We therefore stress the importance of otolaryngological examination upon arrival to the emergency department.


  • Open Access

    The yield of respiratory viruses detection testing is age-dependent in children with acute otitis media

    by Tal Marom, Avital Fellner, Ze’eV Hirschfeld, Tzilia Lazarovitch, Haim Gavriel, Limor Muallem-Kalmovich, Jacob Pitaro

    Studies of nasopharyngeal secretions serve as reliable surrogate to evaluate the involvement of viruses in acute otitis media (AOM) and upper/lower respiratory tract infections (URIs/LRIs). We explored nasopharyngeal viral studies from children with uncomplicated AOM and examined their cost-effectiveness in relation to their age. We identified children aged 0–6 years admitted to our pediatrics department in a university-affiliated, secondary hospital with uncomplicated AOM and concurrent URI/LRI between 2012 and 2017, during October–April, when viral studies are performed. Studies were performed either using antigen detection tests, for respiratory syncytial virus (RSV) and influenza A/B (2012–2016) and for a variety of other common respiratory viruses, utilizing multiplex polymerase chain reaction assays (2017). A total of 249 children were included (median age: 15 months). In 88 (35%) children, viral studies were positive, most of them in children ⩽24 months (78, 89%). RSV was positive in 52 (59%) children, followed by influenza A and B, in 11 (13%) and 5 (6%) children, respectively. First year switch to a molecular assay, 4.5-fold more expensive, resulted in a statistically significant higher yield: 69% positive results in ⩽24 months, and 66% in those aged ⩽12 months (p < 0.05). In those ⩽24 months, US$23 and US$95 were spent for one positive test in the antigen detection years and the polymerase chain reaction year, respectively, whereas in those >24 months, US$83 and US$878 were invested for one positive test in the same year, respectively. In cost-effectiveness terms, the greatest benefit of nasopharyngeal studies was highest in children ⩽24 months.


  • Pediatric neck abscesses: No increase in methicillin-resistant Staphylococcus aureus

    by Avital Fellner, Tal Marom, Limor Muallem-Kalmovich, Nathan Shlamkovitch, Ephraim Eviatar, Tzilia Lazarovitch, Jacob Pitaro